熱門資訊> 正文
BioNTech GAAP每股收益为-1.60欧元，收入为2.608亿欧元
2025-08-04 18:47
- BioNTech press release (NASDAQ:BNTX): Q2 GAAP EPS of -€1.60.
- Revenue of €260.8M (+102.6% Y/Y).
- Revenues for the 2025 financial year €1,700 million - €2,200 million
More on BioNTech
- BioNTech: More Uncertainty Emerges
- BioNTech's Acquisition Of CureVac Brings Complementary Method To Target Cancer
- Bristol-Myers And BioNTech Deal: Good For Both Parties, But One Is The Better Investment
- BioNTech Q2 2025 Earnings Preview
- Experts helping vaccine advisors are reportedly ousted at CDC
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
